News
Parkview Health officials are inviting the public to join in a genetic research project that could result in significant ...
Does heart disease or cancer run in your family? MUSC researchers have created a program to identify whether you’re at an ...
ASTANA – High school textbooks may frame evolution as a thing of the past, but it is very much alive, said Dr. Arkhat ...
Key Takeaways Genetic testing is rapidly moving genomics from a niche specialty to becoming more integrated into mainstream clinical practice. Once deployed primarily to diagnose rare and inherited ...
For centuries, doctors and scientists have agreed that germs are the underlying cause of infectious diseases. Someone coughs ...
The Wyatt Foundation and The Conceive Fertility Foundation continue its mission to support access to fertility care through ...
Just as a computer's operating system can be rewritten after a major update, dengue infection can "re-program" the body's ...
"India is not just a cost center—it’s becoming a core innovation engine for us," said Ankur Dhingra, Chief Financial Officer ...
2don MSN
Drug company, patients bond riding the surf. ‘I just like to feel the wind in my face, too.’
Carlsbad’s Ionis Pharmaceuticals, a biotechnology company, has developed many drugs approved for the treatment of ...
When genetic testing reveals a rare DNA mutation, doctors and patients are frequently left in the dark about what it actually means. Now, researchers at the Icahn School of Medicine at Mount Sinai ...
New treatment targeting CLIC5 gene shows promise in preserving sensory cells in the inner ear, offering hope for millions affected by genetic hearing and balance disorders.
XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | FSE: ANU), a late-stage clinical pharmaceutical company, pivoted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results